AJ

Ashish Jayant Shah

Active Director Director DIN 03116527
DIN 03116527 First appointment Mar 2011 Primary industry Printing & Publishing
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 2 historical roles
Total affiliations 6 Since Mar 2011
Shareholding value •••• Premium profile

About Ashish Jayant Shah

Data last updated:

Ashish Jayant Shah is a Director at Nutan Plastic Works Private Limited (since 2023), Director at Pan -India Drugs & Chemicals Limited (since 2012) and Partner at Vanshi Trading Llp (since 2024), and holds 1 more current directorship. The companies operate in Printing & Publishing, Pharma and Business Services. The 2 current companies with reported revenue have a combined latest revenue of ₹4.26 Cr; the largest is Nutan Plastic Works Private Limited at ₹4.16 Cr (FY 2025). Earlier, Ashish Jayant Shah was a Director at Kaushal Agencies Pvt Ltd (2013–2014) and Director at Rishabh Fintrade Ltd (2011–2020).

DIN 03116527
Primary Designation Director
Industry Printing & Publishing
First Appointment 05 Mar 2011
Oldest Company Age 34 yrs
Largest company Nutan Plastic Works Private Limited · ₹4.16 Cr (FY 2025)
Combined revenue ₹4.26 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nutan Plastic Works Private Limited U22203MH2023PTC406087
Director06 Jul 20232023₹4.16 Cr (FY 2025)Active
Pan -India Drugs & Chemicals Limited U24232MP1992PLC007026
Director31 Aug 20121992₹10 Lakh (FY 2021)Active
Partner10 Feb 20242024Active
Nims Impex Llp ABA-7569
Partner22 Feb 20222022Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kaushal Agencies Pvt Ltd U51909GJ1988PTC010407
Director18 Feb 20131988₹65,468 (FY 2025)Active
Rishabh Fintrade Ltd U67120GJ1993PLC018958
Director05 Mar 20111993₹1.3 Lakh (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Pan -India Drugs & Chemicals Limited
Nims Impex Llp
Vanshi Trading Llp
Nutan Plastic Works Private Limited
Premium access

Shareholding and investment profile for Ashish Jayant Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashish Jayant Shah

Ashish Jayant Shah currently holds 4 directorships: Nutan Plastic Works Private Limited (Director, since 06 Jul 2023, revenue ₹4.16 Cr (FY 2025)); Pan -India Drugs & Chemicals Limited (Director, since 31 Aug 2012, revenue ₹10 Lakh (FY 2021)); Vanshi Trading Llp (Partner, since 10 Feb 2024); Nims Impex Llp (Partner, since 22 Feb 2022).

Ashish Jayant Shah was first appointed on 05 Mar 2011 as Director at Rishabh Fintrade Ltd. The most recent appointment on record is 10 Feb 2024 at Vanshi Trading Llp.

The 2 current companies of Ashish Jayant Shah that report revenue have a combined latest revenue of ₹4.26 Cr: Nutan Plastic Works Private Limited ₹4.16 Cr (FY 2025); Pan -India Drugs & Chemicals Limited ₹10 Lakh (FY 2021).

Ashish Jayant Shah held 2 earlier board appointments: Kaushal Agencies Pvt Ltd (Director, 18 Feb 2013 to 13 Feb 2014); Rishabh Fintrade Ltd (Director, 05 Mar 2011 to 27 Jan 2020).

The current boards of Ashish Jayant Shah's companies include Jayant Seventilal Shah (Nutan Plastic Works Private Limited), Jigar Jayant Shah (Nutan Plastic Works Private Limited), Harshit Devendra Shah (Pan -India Drugs & Chemicals Limited), Lalitchandra Chunilal Shah (Pan -India Drugs & Chemicals Limited), Sagar Mukesh Shah (Vanshi Trading Llp), Nimesh Chandrakant Sheth (Nims Impex Llp).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available